≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Toxic liver disease

DOID EFO Endpoint Browser PheWeb

K11_TOXLIV

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K71
  • Cause of death: ICD-10 — K71

2 out of 7 registries used, show all original rules.

541

4. Check minimum number of events

None

541

5. Include endpoints

None

541

6. Filter based on genotype QC (FinnGen only)

541

Control definitions (FinnGen only)

Control exclude
K11_LIVER

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K70-K77
Name in latin
Morbus hepatis toxicus

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3897 2092 1772
Only index persons 3296 1812 1484
Unadjusted period prevalence (%)
Whole population 0.05 0.06 0.05
Only index persons 0.06 0.07 0.06
Median age at first event (years)
Whole population 56.47 57.86 54.71
Only index persons 55.21 56.21 53.98

-FinnGen-

Key figures

All Female Male
Number of individuals 541 314 227
Unadjusted period prevalence (%) 0.10 0.11 0.10
Median age at first event (years) 54.98 54.18 56.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
483
Matched controls
4832
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K71.2
ICD-10 Finland
Toxic liver disease with acute hepatitis
+∞
244.1
213
*
K71.9
ICD-10 Finland
Toxic liver disease, unspecified
1660.4
134.0
124
*
K71.0
ICD-10 Finland
Toxic liver disease with cholestasis
+∞
76.1
71
*
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
+∞
75.0
70
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
59.8
65.4
76
15
K76.9
ICD-10 Finland
Liver disease, unspecified
206.3
54.2
55
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
44.2
50.5
62
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.9
39.9
108
193
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
39.9
134
316
A05AA02
ATC
ursodeoxycholic acid; oral
41.7
39.6
49
13
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
32.2
39.6
52
18
K71.1
ICD-10 Finland
Toxic liver disease with hepatic necrosis
+∞
39.1
37
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
+∞
28.4
27
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
+∞
26.3
25
*
L04AX01
ATC
azathioprine; systemic
8.9
25.2
55
69
K71.6
ICD-10 Finland
Toxic liver disease with hepatitis, not elsewhere classified
+∞
24.2
23
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
+∞
22.0
21
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
+∞
19.9
19
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
+∞
19.9
19
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.7
19.1
90
279
N05CF01
ATC
zopiclone; oral
2.5
18.2
193
1018
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
17.6
171
859
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.4
17.5
36
41
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
17.4
237
1409
K71.3
ICD-10 Finland
Toxic liver disease with chronic persistent hepatitis
+∞
15.7
15
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
29.7
15.3
20
7
L04AA06
ATC
mycophenolic acid; systemic
12.4
15.2
27
23
K74.3
ICD-10 Finland
Primary biliary cirrhosis
+∞
14.7
14
*
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
+∞
14.7
14
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
37.3
14.5
18
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
14.4
123
564
H02AB06
ATC
prednisolone; systemic
2.1
14.3
250
1616
N05AH04
ATC
quetiapine; oral
2.8
14.3
105
442
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.8
14.0
47
106
ZX120
NOMESCO Finland
Intravenous
3.3
13.5
72
244
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
13.3
94
386
WX892
NOMESCO Finland
Monitored bed care
3.7
12.5
55
160
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
12.5
170
973
A06AD11
ATC
lactulose; oral
2.7
12.4
91
378
R94.5
ICD-10 Finland
Abnormal results of liver function studies
12.9
12.2
21
17
Z94.4
ICD-10 Finland
Liver transplant status
47.9
11.9
14
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.2
11.7
36
74
N05CD07
ATC
temazepam; oral
2.9
11.6
74
283
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
+∞
11.5
11
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
11.5
11
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
11.5
11
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
122.8
11.5
12
*
N07BB01
ATC
disulfiram; oral
4.5
11.4
40
95
D97
ICPC
Liver disease NOS
44.4
11.0
13
*
H02AB04
ATC
methylprednisolone; systemic
2.6
11.0
86
372
R50.9
ICD-10 Finland
Fever, unspecified
2.6
10.9
84
360
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.9
10.9
30
54
N06AX11
ATC
mirtazapine; oral
2.0
10.7
169
1013
K83.0
ICD-10 Finland
Cholangitis
13.3
10.7
18
14
N02AX02
ATC
tramadol; systemic, rectal
1.9
10.6
218
1446
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
+∞
10.5
10
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
10.4
34
75
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.9
10.3
20
21
C10AC01
ATC
colestyramine; oral
5.6
10.3
29
54
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.4
10.2
49
154
A02BC02
ATC
pantoprazole; systemic
1.9
10.2
317
2421
UJF32
NOMESCO Finland
Coloscopy
2.1
10.0
134
750
N05BA04
ATC
oxazepam; oral
2.1
10.0
135
758
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
17.2
9.9
15
9
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
9.8
71
292
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
9.8
91
428
A07EA06
ATC
budesonide; oral, local oral
5.1
9.8
30
62
127
Kela drug reimbursment
Transplant complication
9.4
9.6
19
21
N05BA01
ATC
diazepam; systemic, rectal
2.5
9.5
81
366
L04AD01
ATC
ciclosporin; systemic
7.8
9.5
21
28
K75.4
ICD-10 Finland
Autoimmune hepatitis
+∞
9.4
9
*
C03DA01
ATC
spironolactone; oral
2.8
9.4
61
235
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.3
9.3
24
40
N05AH03
ATC
olanzapine; systemic
3.6
9.3
42
126
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
9.2
64
257
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
8.8
50
177
H02AB07
ATC
prednisone; oral
2.4
8.6
78
363
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.8
8.6
57
223
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
8.5
45
153
K70.0
ICD-10 Finland
Alcoholic fatty liver
91.6
8.4
9
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
13.1
8.4
14
11
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.4
177
1158
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
+∞
8.4
8
*
K71.8
ICD-10 Finland
Toxic liver disease with other disorders of liver
+∞
8.4
8
*
K85
ICD-10 Finland
Acute pancreatitis
7.7
8.2
18
24
UJK02
NOMESCO Finland
ERCP
6.0
8.1
21
36
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
8.1
39
124
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
8.0
118
675
C03CA01
ATC
furosemide; systemic
1.9
8.0
136
824
N06AX12
ATC
bupropion; oral
3.4
8.0
38
119
R53
ICD-10 Finland
Malaise and fatigue
2.0
7.9
110
617
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
7.4
51
205
N06AB04
ATC
citalopram; systemic
2.0
7.4
108
616
K71.7
ICD-10 Finland
Toxic liver disease with fibrosis and cirrhosis of liver
+∞
7.3
7
*
JJ5AT
NOMESCO Finland
NA
+∞
7.3
7
*
K71.4
ICD-10 Finland
Toxic liver disease with chronic lobular hepatitis
+∞
7.3
7
*
N03AX16
ATC
pregabalin; oral
1.9
7.3
119
705
L04AA01
ATC
[U] ciclosporin; systemic
7.5
7.2
16
22
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.2
85
444
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.2
178
1211
TK800
NOMESCO Finland
Hemodialysis
5.2
7.2
21
42
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.1
113
664
J01MA12
ATC
levofloxacin; systemic
2.0
7.1
92
502
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.9
7.0
27
72
M05BA04
ATC
alendronic acid; oral
2.7
6.8
44
170
K83.1
ICD-10 Finland
Obstruction of bile duct
9.5
6.8
13
14
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.8
6.8
18
32
C07AA05
ATC
propranolol; systemic
1.9
6.8
99
564
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.8
6.8
21
45
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
40.6
6.8
8
*
A02BC05
ATC
esomeprazole; systemic
1.7
6.7
190
1342
N05AX12
ATC
aripiprazole; systemic
3.7
6.6
27
76
K92.0
ICD-10 Finland
Haematemesis
5.5
6.5
18
34
A07EC02
ATC
mesalazine; oral, rectal
3.1
6.5
34
116
N03AE01
ATC
clonazepam; systemic
3.1
6.5
34
116
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
6.5
74
381
K76.89
ICD-10 Finland
Other specified diseases of liver
70.7
6.4
7
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
6.4
29
89
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.4
6.3
12
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.3
61
294
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
6.3
56
259
K72.1
ICD-10 Finland
Chronic hepatic failure
+∞
6.3
6
*
K71.5
ICD-10 Finland
Toxic liver disease with chronic active hepatitis
+∞
6.3
6
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
6.2
62
301
R4110
NOMESCO Finland
Physiotherapy
1.8
6.2
133
858
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
6.2
35
123
F05.9
ICD-10 Finland
Delirium, unspecified
5.9
6.2
16
28
P76
ICPC
Depressive disorder
3.0
6.2
35
124
L88
ICPC
Rheumatoid/seropositive arthritis
3.8
6.2
24
65
P01BA02
ATC
hydroxychloroquine; oral
2.5
6.2
46
193
L04AA13
ATC
leflunomide; oral
4.5
6.1
20
46
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.7
6.0
16
29
WX882
NOMESCO Finland
High dependency care
4.7
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006922) Hepatitis E virus Ab [Presence] in Serum
91
13
83.95
170.44
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
90
12
89.77
170.23
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
90
12
89.77
170.23
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
97
48
24.40
130.42
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
99
54
22.22
127.61
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
202
344
8.78
123.67
3.9
2.1
g/l
0.2
0.2
3.84
186
325
(3005719) IgG [Mass/volume] in Serum or Plasma
183
293
8.93
117.77
2.4
2.6
g/l
10.5
10.2
0.55
176
269
(3028026) IgM [Mass/volume] in Serum or Plasma
166
239
9.58
116.73
1.5
1.8
g/l
1.3
1.6
0.53
157
221
(3023183) Ammonium ion [Moles/volume] in Plasma
92
65
16.85
103.95
4.9
2.6
umol/l
39.1
31.2
0.88
84
53
(3017143) Hepatitis C virus Ab [Presence] in Serum
203
445
6.70
95.23
1.7
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
63
25
28.39
91.42
1.3
1.0
titre
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
201
478
6.10
85.51
7.3
2.4
umol/l
26.3
7.4
4.73
186
421
(40768441) Liver Pathology biopsy report
55
21
29.04
80.70
1.7
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
213
579
5.42
76.91
1.7
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
80
78
11.86
73.84
4.1
6.6
iu/ml
1177.3
495.9
—
8
11
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
76
76
11.47
68.84
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
75
74
11.61
68.55
1.2
1.3
u/ml
231.3
236.1
0.04
49
42
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
329
1415
4.38
62.88
9.7
3.1
u/l
111.2
30.2
4.40
318
1348
(3037522) Nuclear Ab [Titer] in Serum
194
569
4.76
62.19
1.6
1.3
titre
494.0
467.5
0.10
40
131
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
51
31
18.06
61.52
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
85
117
8.43
60.21
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
370
1774
4.43
59.71
9.6
4.3
g/l
34.5
36.0
5.80
356
1650
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
64
68
10.54
55.29
1.5
1.4
u/ml
95.7
110.3
—
10
15
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
412
2240
4.52
53.19
15.2
5.8
umol/l
22.8
10.9
6.54
401
2123
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
64
72
9.95
52.99
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
65
75
9.71
52.80
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
124
306
4.96
48.19
1.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
216
843
3.60
44.15
1.7
1.4
g/l
2.4
2.3
0.38
167
514
(42870588) Differential panel, method unspecified - Blood
296
1427
3.37
42.63
10.1
5.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
74
127
6.59
42.50
1.2
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
245
1060
3.40
42.09
10.9
3.4
%
86.4
92.5
2.83
240
1034
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
284
1348
3.33
41.75
4.5
2.4
u/l
55.7
55.9
0.03
272
1256
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
547
3.77
40.16
3.0
2.3
%
26.6
22.6
1.85
143
477
(3006315) Basophils [#/volume] in Blood
369
2160
3.23
35.91
10.6
5.9
e9/l
0.0
0.0
1.10
325
1879
(3001604) Monocytes [#/volume] in Blood
368
2151
3.22
35.90
10.5
5.8
e9/l
0.6
0.6
0.73
325
1871
(3004789) Transferrin [Mass/volume] in Serum or Plasma
161
588
3.47
35.47
3.2
2.2
g/l
2.3
2.4
0.43
150
547
(3013115) Eosinophils [#/volume] in Blood
374
2227
3.20
34.90
11.3
6.3
e9/l
0.2
0.2
0.02
338
1971
(3032080) INR in Blood by Coagulation assay
310
1678
2.98
34.10
10.8
7.6
inr
1.2
1.2
0.01
95
504
(3019198) Lymphocytes [#/volume] in Blood
369
2210
3.11
33.49
10.7
5.9
e9/l
1.9
1.9
0.43
333
1961
(3022096) Basophils/100 leukocytes in Blood
339
1951
2.98
32.86
10.7
5.9
%
0.7
0.7
1.50
324
1820
(3019069) Monocytes/100 leukocytes in Blood
347
2029
2.98
32.53
10.9
6.2
%
8.8
8.6
0.80
330
1907
(3020779) Urea [Moles/volume] in Serum or Plasma
111
335
3.91
32.34
12.7
6.7
mmol/l
8.7
9.2
0.31
103
320
(3006504) Eosinophils/100 leukocytes in Blood
345
2020
2.95
32.10
10.7
5.9
%
2.8
2.8
0.03
329
1884
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
122
396
3.69
31.94
4.7
2.1
u/l
49.1
33.6
0.51
109
334
(3022948) Iron [Moles/volume] in Serum or Plasma
163
641
3.21
31.38
3.3
2.3
umol/l
14.6
13.3
0.98
157
589
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
78
6.96
31.25
1.1
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
347
2079
2.87
30.17
10.7
6.0
%
27.6
28.3
0.50
330
1945
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
141
521
3.31
29.97
3.1
1.8
%
1.7
1.5
3.35
126
464
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
29
23
13.27
29.97
6.1
1.7
%
102.1
104.5
0.09
29
23
(3018010) Neutrophils/100 leukocytes in Blood
340
2049
2.77
28.64
10.3
5.8
%
57.3
57.0
0.20
326
1928
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
466
3346
3.83
28.28
19.7
7.1
u/l
115.6
76.8
10.10
453
3129
(3013650) Neutrophils [#/volume] in Blood by Automated count
388
2525
2.90
27.74
16.1
9.1
e9/l
4.2
4.0
0.96
349
2204
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
24
17
14.73
26.36
1.9
2.7
umol/l
160.3
102.2
—
11
10
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
315
1895
2.59
25.53
10.1
5.7
mmol/l
1.2
1.2
2.10
295
1719
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
25
11.31
25.29
1.6
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
119
443
3.16
24.58
5.8
4.4
u/l
256.2
254.0
0.04
112
421
(3018418) pH of Serum or Plasma
233
1246
2.53
23.84
6.2
3.8
ph
7.4
7.4
0.25
47
233
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
420
2974
2.84
23.29
8.7
2.9
u/l
123.1
43.0
7.91
403
2786
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
329
2082
2.48
23.00
12.1
6.5
mmol/l
1.2
1.2
0.65
273
1760
(3023368) Bacteria identified in Blood by Culture
214
1119
2.51
22.75
6.0
3.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
94
334
3.20
20.79
12.5
7.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
145
659
2.64
20.34
6.3
3.3
mmol/l
0.8
0.8
0.58
140
625
(3027945) Reticulocytes/100 erythrocytes in Blood
113
454
2.88
20.10
4.1
2.7
%
2.1
1.8
1.72
99
410
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
258
1530
2.31
20.01
4.4
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1030
2.40
19.74
3.1
2.1
mg/l
2.6
3.1
2.81
167
887
(3030467) Casts [#/volume] in Urine by Automated count
214
1185
2.33
19.36
4.1
2.9
e6/l
0.6
0.4
0.60
169
876
(36304419) Bacteria [Presence] in Urine
210
1155
2.34
19.29
3.9
2.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
28
8.92
19.03
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
121
529
2.66
18.16
10.2
5.3
mmol/l
1.0
1.0
0.03
115
494
(3018095) Leukocytes [#/volume] in Urine
250
1507
2.23
18.15
4.9
3.6
e6/l
96.5
101.9
0.03
181
1065
(46235355) HIV 1 and 2 tests - Meaningful Use set
151
735
2.46
18.10
2.1
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
142
673
2.50
18.02
2.1
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
90
340
2.98
17.78
3.7
2.7
e9/l
79.3
70.4
0.99
68
260
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
13
13.47
17.74
3.7
2.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
293
1894
2.19
17.72
4.3
2.7
ug/l
319.7
116.1
2.05
268
1750
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
60
5.79
17.64
1.3
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
221
1287
2.21
17.28
4.3
3.0
e6/l
52.7
111.6
0.54
176
984
(3013826) Glucose [Moles/volume] in Serum or Plasma
358
2529
2.23
17.01
9.5
4.6
mmol/l
6.7
6.7
0.01
338
2352
(3021589) Normoblasts [#/volume] in Blood
297
1956
2.15
16.81
15.4
9.2
e9/l
0.0
0.0
0.51
245
1619
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
99
4.52
16.74
3.5
2.4
u/ml
0.3
0.3
0.63
23
54
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
107
464
2.63
16.19
1.9
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
195
1107
2.19
16.00
10.6
6.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
107
470
2.59
15.75
1.9
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
175
969
2.19
15.14
1.3
1.2
u/ml
0.9
1.4
0.45
32
275
(3013707) Erythrocyte sedimentation rate by Westergren method
421
3252
2.33
15.02
6.9
4.0
mm/h
16.6
11.4
7.21
394
2993
(3026008) Bacteria identified in Urine by Culture
205
1217
2.10
14.75
3.5
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
395
2986
2.20
14.67
6.1
4.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
162
887
2.18
14.30
3.4
2.4
e6/l
6.0
6.0
0.03
151
785
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
76
298
2.80
13.90
1.8
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
305
2123
2.00
13.82
4.5
3.6
estimate
0.0
0.0
0.00
57
402
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
264
1754
1.99
13.61
3.4
2.2
nmol/l
76.2
76.3
0.01
248
1567
(3002032) Base excess in Venous blood by calculation
88
376
2.60
13.60
7.5
4.0
mmol/l
1.4
2.0
0.94
76
302
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
137
714
2.23
13.59
3.4
2.6
e6/l
1.4
1.0
0.51
81
394
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
17
9.67
13.50
1.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
211
1302
2.02
13.38
2.9
2.0
u/l
138.7
235.8
1.14
200
1224
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
153
3.42
13.21
3.4
2.9
u/ml
18.8
1289.4
0.79
42
132
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
38
100
4.01
13.12
1.3
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
150
829
2.12
12.73
3.0
2.7
mosm/kgh2o
525.8
550.8
0.70
137
710
(3021960) Folate [Moles/volume] in Serum or Plasma
171
993
2.06
12.71
1.7
1.5
nmol/l
19.2
21.5
1.11
153
839
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
128
666
2.21
12.66
3.6
2.8
e6/l
2.9
2.2
0.37
72
347
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
799
2.09
12.01
5.6
3.8
ng/l
295.3
310.7
0.04
117
600
(3028707) Methadone [Presence] in Urine by Screen method
32
80
4.19
11.82
11.9
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
164
965
2.00
11.59
4.1
3.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
177
3.08
11.57
1.9
2.0
g/l
1.3
1.5
0.97
45
157
(3009261) Glucose [Presence] in Urine by Test strip
300
2168
1.86
11.21
4.5
3.6
estimate
0.0
0.0
0.50
55
389
(3009508) Creatinine [Moles/volume] in Urine
207
1334
1.89
11.09
5.1
3.2
mmol/l
7.9
7.7
0.20
171
1108
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
246
1682
1.85
10.88
2.3
1.9
pmol/l
97.5
96.5
0.10
128
850
(3015377) Calcium [Moles/volume] in Serum or Plasma
219
1452
1.85
10.63
4.3
3.3
mmol/l
2.3
2.4
0.31
192
1278
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
94
462
2.25
10.55
9.7
7.6
kpa
4.9
5.1
0.99
87
444
(3027801) Oxygen [Partial pressure] in Arterial blood
94
462
2.25
10.55
9.7
7.6
kpa
11.4
12.2
0.97
87
447
(3021601) Nitrite [Presence] in Urine by Test strip
294
2137
1.82
10.53
5.8
4.8
estimate
0.0
0.0
0.50
57
405
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
27
6.47
10.33
2.5
1.4
g/l
0.9
1.0
0.50
17
27
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
15
8.86
10.27
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
114
612
2.09
10.22
2.9
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
11
10
11.21
10.19
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
10
11.21
10.19
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
99
515
2.13
9.60
19.1
21.1
inr
1.0
1.3
4.85
12
70
(3024928) Oxygen saturation in Venous blood
31
89
3.63
9.48
3.6
5.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
94
3.56
9.47
1.5
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
91
461
2.17
9.43
10.0
7.7
mmol/l
1.1
1.1
0.03
61
370
(3017181) Myelocytes/100 leukocytes in Blood
76
361
2.29
9.20
5.0
4.0
%
1.0
0.8
0.22
27
115
(3019309) Folate [Moles/volume] in Red Blood Cells
127
735
1.95
9.16
1.9
1.7
nmol/l
1217.3
1188.8
0.10
100
558
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
83
411
2.20
9.09
3.4
4.2
ug/l
27.7
18.5
0.14
72
333
(1001926) Buprenorphine [Presence] in Urine by Screen method
36
119
3.17
8.87
10.2
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
70
328
2.30
8.74
5.3
3.9
%
0.5
0.4
0.03
20
83
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
36
5.14
8.67
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
100
3.34
8.63
1.4
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
40
145
2.90
8.42
7.8
3.3
mg/l
1.6
1.5
0.48
40
132
(3016879) Cocaine [Presence] in Urine
39
140
2.92
8.36
10.2
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
157
999
1.81
8.33
7.7
4.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
60
3.96
8.05
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
196
1343
1.72
7.98
4.5
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
35
4.98
7.93
1.3
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
69
337
2.20
7.79
5.2
4.1
%
0.1
0.1
0.02
25
104
(3036489) Thrombin time
40
152
2.76
7.73
3.2
2.1
s
22.3
21.6
0.21
34
138
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
40
4.62
7.70
2.4
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
39
147
2.78
7.66
10.3
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
147
2.78
7.66
10.3
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
12
18
6.80
7.63
4.3
1.4
umol/l
25.8
30.8
0.81
12
18
(3007853) Bacteria identified in Skin by Aerobe culture
91
499
1.99
7.57
2.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
148
2.76
7.56
10.3
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
30
100
3.12
7.31
21.5
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
146
954
1.73
6.90
6.6
3.9
kg/l
1.0
1.0
0.39
21
127
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
265
2018
1.61
6.89
5.7
3.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
83
3.24
6.80
4.9
3.3
e9/l
3.5
4.1
0.65
26
83
(40768797) Stomach Pathology biopsy report
100
589
1.86
6.69
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
45
4.10
6.67
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
154
2.58
6.50
3.7
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
63
320
2.10
6.44
5.3
4.2
%
0.0
0.1
0.66
20
90
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
86
3.13
6.43
5.3
3.7
%
54.3
56.1
0.27
26
86
(4035726)
70
371
2.02
6.38
1.5
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
47
213
2.32
6.34
13.8
8.6
mmol/l
23.6
24.5
1.18
40
203
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
488
4405
2.10
6.32
29.5
13.2
mg/l
20.3
22.7
1.17
435
3444
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
151
1018
1.67
6.29
4.4
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
123
788
1.73
6.17
4.0
2.8
mmol/l
2.5
2.4
1.06
102
688
(3027944) Amphetamines [Presence] in Urine
36
146
2.57
6.16
11.1
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
83
3.11
6.15
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
83
3.11
6.15
1.6
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
243
2.21
6.12
1.8
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
148
2.53
6.00
1.8
1.6
iu/ml
0.0
0.0
—
6
26
(3019060) Gas panel - Arterial blood
53
260
2.15
5.92
4.2
6.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
496
4525
2.16
5.91
31.2
15.0
mmol/l
139.1
139.7
5.54
485
4397
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
441
1.90
5.90
4.3
3.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
32
126
2.64
5.81
3.9
2.2
%
81.3
92.7
1.26
32
119
(3042733) HLA Ab [Presence] in Serum
10
9
11.29
5.81
4.7
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
174
1237
1.60
5.79
3.8
3.3
mg/l
44.3
328.3
1.63
109
774
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
258
2.12
5.65
1.7
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
52
258
2.12
5.65
3.3
3.7
pmol/l
4.3
4.5
0.63
44
226
(3023103) Potassium [Moles/volume] in Serum or Plasma
496
4539
2.12
5.63
31.6
15.1
mmol/l
3.9
4.0
1.09
485
4405
(3008152) Bicarbonate [Moles/volume] in Arterial blood
51
252
2.13
5.60
6.7
8.3
mmol/l
23.3
24.5
1.05
46
236
(3002385) Erythrocyte distribution width [Ratio]
424
3707
1.66
5.57
35.3
16.2
%
14.2
13.6
5.24
417
3639
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
29
4.57
5.53
2.0
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
62
332
1.98
5.49
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
37
161
2.39
5.48
7.0
4.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
179
1299
1.56
5.39
4.4
4.1
mg/mmol
9.5
7.3
0.25
110
804
(3048689) Calprotectin [Mass/mass] in Stool
88
534
1.77
5.30
3.3
2.5
ug/g
134.8
137.8
0.03
69
430
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
36
158
2.37
5.24
1.7
1.8
ug/l
1.6
3.7
0.51
31
144
(3018405) Lactate [Moles/volume] in Arterial blood
34
146
2.42
5.19
3.7
3.7
mmol/l
1.6
1.3
1.02
34
141
(3052851) Hemolysis interference index of Serum or Plasma
29
118
2.54
4.96
5.2
2.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
31
131
2.45
4.91
2.3
2.0
ug/l
478.2
289.0
0.48
31
122
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
215
1657
1.49
4.77
4.6
3.6
ng/l
100.5
37.8
0.60
146
1128
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
43
212
2.12
4.77
5.4
3.4
%
1.2
1.2
0.06
43
212
(3012501) Base excess in Blood by calculation
23
85
2.78
4.74
3.2
2.8
mmol/l
1.9
2.9
1.32
12
57
(3026493) Urate [Moles/volume] in Serum or Plasma
157
1134
1.54
4.73
3.3
2.6
umol/l
4487.3
5752.5
0.15
142
975
(3044889) 12 lead EKG panel
359
3073
1.50
4.66
4.8
3.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
5
14.16
4.58
2.6
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
449
4048
1.64
4.51
6.1
4.7
mu/l
1.9
2.2
0.45
423
3699
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
49
3.33
4.50
3.7
3.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
76
2.83
4.50
1.7
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
125
2.39
4.42
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
32
145
2.28
4.37
3.9
3.6
g/l
0.2
0.2
0.12
14
53
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
78
2.76
4.30
1.8
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
108
2.48
4.29
1.7
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
141
2.27
4.20
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
31
141
2.27
4.20
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
104
2.47
4.12
1.7
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
47
3.25
4.08
1.9
2.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
47
3.25
4.08
2.1
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
143
2.24
4.07
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
14
43
3.32
3.93
1.4
1.1
nmol/l
1.3
1.7
0.42
14
36
(1616796) Gas panel - Central venous blood
22
88
2.56
3.93
3.4
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
38
3.48
3.92
5.6
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
40
208
2.00
3.88
12.5
11.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
120
2.32
3.87
1.6
1.4
ug/g
351.8
329.0
0.21
19
68
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
367
1.75
3.78
3.0
2.4
ug/l
7.5
7.1
0.07
53
325
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
34
3.59
3.78
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
34
3.59
3.78
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
34
3.59
3.78
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
8
8.84
3.78
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
78
2.62
3.76
1.2
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
135
2.21
3.74
3.1
2.2
u/l
1038.1
2657.5
—
9
48
(3022145) Colonoscopy Study observation
77
496
1.64
3.72
1.6
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
35
3.48
3.63
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
35
3.48
3.63
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
35
3.48
3.63
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
341
1.75
3.61
4.2
3.6
mmol/l
1.2
1.2
1.18
52
298
(3002256) Pathology report gross observation
83
550
1.60
3.58
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
131
2.20
3.58
4.1
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
125
2.22
3.54
1.5
2.9
mg/l
37.2
94.7
0.60
22
101
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
125
2.22
3.54
1.5
2.9
mg/l
26.3
30.0
0.44
22
101
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
133
980
1.47
3.53
2.3
1.7
mg/l
1.7
1.1
0.71
106
748
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
106
2.32
3.50
2.1
1.9
iu/l
3.0
6.6
—
6
38
(3004809) Band form neutrophils/100 leukocytes in Blood
18
69
2.66
3.50
4.4
3.2
%
0.8
1.0
0.24
12
55
(3013293) Extractable nuclear Ab [Presence] in Serum
6
6
10.09
3.50
1.5
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
6
10.09
3.50
1.0
3.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
31
3.60
3.50
1.5
1.6
—
—
—
0
0
(44790049)
15
52
2.94
3.49
1.5
1.7
—
—
—
0
0
(44790048)
15
52
2.94
3.49
1.5
1.7
—
—
—
0
0
(44790047)
15
52
2.94
3.49
1.5
1.7
—
—
—
0
0
(44806118)
15
52
2.94
3.49
1.5
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
81
541
1.58
3.38
1.8
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
10
7.07
3.37
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
209
1687
1.39
3.33
4.9
3.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
43
3.07
3.27
2.1
1.8
—
—
—
0
0
(4062490)
12
38
3.21
3.23
1.6
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
15
5.40
3.20
1.8
1.5
nmol/l
126.3
126.8
—
8
15
(3022493) Free Hemoglobin [Mass/volume] in Plasma
8
15
5.40
3.20
1.5
1.0
mg/l
38.4
77.4
—
8
10
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
376
3355
1.40
3.15
5.3
3.9
pmol/l
14.8
14.7
0.36
353
3047
(40768804) Tissue Pathology biopsy report
214
1748
1.37
3.12
2.3
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
86
2.38
3.11
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
119
879
1.45
3.10
1.8
1.7
pmol/l
158824078.0
5494939.2
0.47
102
728
(3029937) Albumin [Presence] in Urine by Test strip
152
1176
1.41
3.07
5.7
3.8
estimate
0.0
0.0
0.69
57
398
(3004588) Protein electrophoresis panel - Serum or Plasma
46
273
1.75
3.02
1.6
2.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
150
1164
1.40
2.96
1.9
1.7
mmol/l
1.5
1.4
0.40
133
987
(40760888) Immunoglobulin light chains.free panel - Serum
20
89
2.30
2.90
1.5
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
246
1.77
2.89
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
47
2.81
2.83
2.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
59
2.59
2.81
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
42
2.90
2.76
1.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
42
2.90
2.76
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
42
2.90
2.76
1.7
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
118
2.08
2.76
1.6
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
14
5.05
2.73
2.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
66
2.47
2.73
1.1
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
147
1.95
2.70
1.6
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.4
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
126
2.03
2.70
1.3
1.3
miu/ml
488.2
226.1
—
6
65
(3045414) Leukocytes [Presence] in Urine
34
191
1.83
2.69
3.2
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
24
3.79
2.68
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
152
1200
1.37
2.68
2.8
3.1
ng/l
1863.5
1068.5
0.89
134
1009
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
43
2.83
2.66
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
497
4722
1.65
2.61
26.3
9.9
u/l
58.5
26.3
3.90
488
4553
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
87
2.23
2.60
2.9
2.2
g/l
132.9
127.7
0.29
14
64
(1761868) Lipid panel - Serum or Plasma
133
1674
0.73
2.59
3.2
2.8
—
—
—
0
0
(4198724)
8
20
4.04
2.57
6.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
320
2829
1.32
2.57
3.2
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
57
375
1.58
2.56
5.4
3.5
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
6
11
5.50
2.55
3.5
8.0
mmol/l
22.9
25.9
—
6
11
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
19
88
2.20
2.54
1.6
1.3
mmol/l
3.5
3.8
0.61
19
82
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
13
51
2.59
2.46
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
70
2.32
2.43
1.3
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
34
2.98
2.42
24.6
17.4
nmol/l
1705.9
1699.1
—
10
34
(3008536) Aspergillus sp Ab [Presence] in Serum
6
12
5.04
2.40
4.7
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
27
3.37
2.40
6.7
2.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
84
2.18
2.37
2.7
2.5
%
18.4
15.8
—
7
44
(3028433) Virus identified in Specimen by Culture
8
22
3.67
2.37
2.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
247
0.39
2.36
1.7
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
44
278
1.63
2.34
6.1
3.5
ph
7.4
7.4
—
6
35
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
28
3.25
2.31
1.6
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
28
3.25
2.31
1.6
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
92
2.10
2.30
3.5
2.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
41
2.72
2.29
1.3
2.1
e9/l
1.4
1.3
—
6
19
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
18
3.92
2.26
1.6
2.1
ug/l
57.1
81.0
—
7
18
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
47
305
1.59
2.25
1.2
1.2
iu/ml
167.0
141.1
0.16
18
128
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
9
5.59
2.22
1.2
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
235
1.66
2.20
1.2
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
61
2.33
2.16
1.1
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
366
1.53
2.16
5.2
3.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
19
3.72
2.15
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
14
4.32
2.15
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
68
2.24
2.13
1.2
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
49
2.48
2.11
1.7
1.8
pg
33.8
32.9
0.25
12
49
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
446
4185
1.37
2.11
25.2
12.0
ml/min/173m2
81.5
81.9
0.13
393
3451
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
25
3.23
2.10
1.1
2.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
36
223
1.66
2.08
1.3
1.1
—
6.2
—
0
5
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
154
1.79
2.08
2.4
1.6
—
—
—
0
0
(3019225) pH of Specimen
57
395
1.50
2.06
8.5
4.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
264
1.60
2.05
6.3
3.5
mmol/l
0.8
1.6
0.57
33
196
(3003327) Ova and parasites identified in Stool by Light microscopy
26
149
1.78
1.98
1.9
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
21
3.36
1.97
1.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
64
2.22
1.96
1.5
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
11
4.58
1.94
1.0
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
11
4.58
1.94
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
31
190
1.67
1.88
1.3
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
100
1.93
1.87
1.6
1.4
mg/l
521.7
441.6
0.61
19
95
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
115
1.86
1.85
1.3
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
115
1.86
1.85
1.6
1.2
u/l
12.8
9.6
0.39
14
90
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.56
1.84
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
143
1179
1.29
1.81
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
146
1.75
1.81
2.8
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
35
2.60
1.81
1.8
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
29
2.78
1.79
1.3
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
47
2.37
1.78
1.5
1.5
g/l
31.1
33.9
0.23
11
42
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
41
2.47
1.76
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
41
2.47
1.76
1.5
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
18
3.36
1.75
1.2
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
54
2.25
1.75
4.7
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
163
1.69
1.75
2.8
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
40
268
1.53
1.72
4.1
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
48
2.32
1.71
1.6
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
55
2.21
1.68
1.6
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
483
4631
1.40
1.65
25.1
12.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
14
3.59
1.62
10.6
12.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
145
1214
1.27
1.61
4.2
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
479
0.65
1.61
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
77
1.98
1.60
1.9
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
450
4275
1.31
1.58
5.0
4.4
mmol/l
6.2
5.9
2.28
420
3918
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
20
3.02
1.58
1.7
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
33
2.45
1.54
5.6
8.2
%
11.0
10.9
—
8
33
(3009542) Hematocrit [Volume Fraction] of Blood
430
4068
1.28
1.51
32.4
14.1
%
38.9
40.1
2.18
315
3011
(3011985) Renin [Units/volume] in Plasma
11
51
2.18
1.51
1.5
1.2
mu/l
73.4
53.6
0.25
11
46
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
370
1.42
1.50
6.5
2.7
ml/min/173m2
58.0
67.1
0.66
18
154
(4010399)
44
311
1.45
1.49
1.6
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
80
1.90
1.46
1.9
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
59
2.06
1.44
1.8
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
39
2.33
1.43
1.4
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
39
2.33
1.43
1.8
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
29
2.43
1.39
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
60
2.02
1.39
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
60
2.02
1.39
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
60
2.02
1.39
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
60
2.02
1.39
1.8
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
104
1.76
1.38
1.8
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
104
1.76
1.38
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
296
0.59
1.37
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
27
175
1.57
1.37
7.7
3.8
mmol/l
24.8
24.8
0.01
27
169
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
2.6
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
2.6
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
61
1.99
1.33
1.8
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
209
1.51
1.33
7.8
3.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
43
2.11
1.31
1.2
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
24
2.52
1.30
1.8
4.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.30
2.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.30
2.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.30
2.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.30
2.3
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
18
2.79
1.28
2.6
1.9
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
18
2.79
1.28
1.6
1.9
nmol/l
2.0
13.1
—
5
13
(21494890) Protein electrophoresis panel - 24 hour Urine
8
35
2.30
1.27
1.1
2.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
95
780
1.26
1.24
1.3
1.3
iu/ml
30.5
31.6
0.04
27
252
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
25
2.42
1.24
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
25
2.42
1.24
1.7
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
19
2.65
1.22
1.8
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
26
2.32
1.19
1.7
3.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
50
2.02
1.17
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
21
2.39
1.09
3.6
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
41
1.97
1.09
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
41
1.97
1.09
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
41
1.97
1.09
2.8
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
194
1.47
1.09
1.5
1.3
iu/l
22.5
26.5
0.30
19
165
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
121
1.59
1.07
1.6
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
121
0.49
1.06
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
98
1.65
1.04
2.4
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
35
2.01
1.00
1.1
1.1
mg/l
33.3
30.3
—
7
29
(4024509)
7
35
2.01
1.00
1.6
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
49
1.85
0.99
1.6
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
23
2.18
0.98
2.8
3.1
u/ml
1548.0
861.3
—
5
23
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.0
u/l
181.4
93.3
—
5
18
(3000012) Reticulocyte production index
5
23
2.18
0.98
1.2
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.0
u/l
73.6
35.5
—
5
18
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
454
4380
1.23
0.98
5.3
4.4
mmol/l
4.7
4.7
0.26
427
4075
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
424
4069
1.19
0.94
7.2
5.6
mmol/mol
40.5
39.7
0.63
400
3802
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
53
421
1.29
0.93
2.3
2.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
55
1.83
0.92
1.2
1.3
nmol/l
0.6
0.6
—
10
49
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
62
505
1.26
0.90
1.8
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
764
1.21
0.90
1.4
1.3
u/ml
6.0
9.7
0.37
30
299
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
93
793
1.21
0.89
1.3
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
95
1.60
0.88
1.3
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
82
693
1.22
0.86
1.5
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
58
472
1.26
0.85
2.4
2.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
31
1.95
0.84
1.2
1.0
—
—
—
0
0
(4268621)
8
45
1.79
0.84
2.6
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
46
365
1.28
0.83
2.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
165
0.60
0.83
1.7
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
46
1.75
0.83
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
429
0.75
0.82
1.8
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3013512) EKG study
141
1260
1.16
0.79
3.9
3.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
450
4362
1.19
0.78
5.1
4.3
mmol/l
1.5
1.5
0.05
421
4043
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
115
1.49
0.77
1.2
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
107
1.51
0.77
1.8
1.5
e6/l
8819.3
16175.6
—
9
80
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
149
1.43
0.76
1.5
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
300
1.29
0.73
2.9
3.0
e9/l
3.3
4.0
1.99
29
237
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
56
1.62
0.72
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
41
1.72
0.70
2.7
2.8
—
—
—
0
0
(4146454)
7
41
1.72
0.70
4.0
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.1
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
2.8
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
1072
0.86
0.64
3.6
4.1
%
24.6
21.3
0.94
38
497
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(4027681)
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
50
416
1.22
0.64
1.2
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
458
4465
1.17
0.63
5.9
4.8
mmol/l
2.7
2.8
1.84
434
4130
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.1
1.2
nmol/l
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
139
1.38
0.61
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
211
1.29
0.58
3.4
3.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
501
4928
1.23
0.57
43.1
19.5
e9/l
248.6
251.6
0.42
486
4807
(3000034) Microalbumin [Mass/volume] in Urine
6
36
1.67
0.57
2.8
4.0
mg/l
13.1
21.1
—
6
29
(3045788) Cell count panel - Pleural fluid
6
36
1.67
0.57
1.0
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
36
1.67
0.57
1.7
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
37
1.63
0.55
1.0
1.2
u/ml
—
0.1
—
0
18
(3024731) MCV [Entitic volume]
501
4930
1.22
0.55
42.9
19.5
fl
91.7
90.9
2.91
492
4861
(3035941) MCH [Entitic mass]
501
4931
1.22
0.54
42.9
19.4
pg
30.4
30.3
0.86
492
4861
(3010813) Leukocytes [#/volume] in Blood
501
4932
1.21
0.53
43.2
19.6
e9/l
6.9
6.7
1.83
486
4800
(3026361) Erythrocytes [#/volume] in Blood
501
4932
1.21
0.53
43.1
19.5
e12/l
4.4
4.5
5.64
487
4799
(4306422)
9
62
1.46
0.53
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
83
1.46
0.52
3.2
2.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
501
4934
1.21
0.52
43.2
19.6
g/l
131.7
135.7
6.56
492
4864
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
41
1.47
0.50
5.5
2.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
119
1.36
0.48
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
37
310
1.21
0.47
2.0
2.2
nmol/l
12.7
13.3
0.18
32
285
(3008898) HLA-B27 [Presence]
14
187
0.74
0.46
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
230
1.23
0.43
2.6
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
412
0.84
0.42
1.2
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
33
1.52
0.41
2.4
2.9
—
48.1
—
0
8
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
215
1.22
0.39
2.4
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
114
0.70
0.37
2.1
4.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
43
1.40
0.35
6.5
3.1
u/ml
120.9
54.8
—
6
43
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
71
779
0.90
0.34
2.8
3.0
ug/l
0.7
0.7
0.36
43
490
(3045424) Erythrocytes [Presence] in Urine
11
82
1.35
0.34
2.6
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(4034850)
18
148
1.22
0.29
11.4
9.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
125
1323
0.93
0.28
4.5
4.7
ug/l
2.0
2.4
0.60
114
1192
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
58
529
1.11
0.27
11.4
6.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
64
1.25
0.27
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
180
1.17
0.24
2.5
1.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.6
ug/l
15.4
17.8
—
5
42
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.2
—
2.7
—
0
5
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.6
—
0
6
(44806420)
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
104
0.77
0.21
1.8
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
186
0.86
0.19
1.3
1.9
mg/l
1.7
2.8
0.95
11
133
(3025130) Human papilloma virus identified in Specimen
6
52
1.16
0.19
1.5
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
427
4223
1.05
0.17
4.9
3.9
mmol/l
1.3
1.3
0.71
398
3899
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
70
0.71
0.17
1.4
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
79
1.14
0.15
1.3
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
51
542
0.93
0.14
5.6
4.4
%
32.6
31.6
0.24
42
362
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
87
0.80
0.14
1.9
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
96
0.83
0.14
1.6
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
99
0.81
0.13
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
99
0.81
0.13
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
99
0.81
0.13
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
99
0.81
0.13
1.6
1.4
—
—
—
0
0
(1002224) Polysomnography panel
23
210
1.10
0.12
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
146
0.89
0.10
1.5
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.0
u/ml
—
6.5
—
0
9
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
116
1.12
0.09
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
48
1.04
0.09
1.4
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
61
0.82
0.08
1.0
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
66
1.06
0.08
1.9
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
85
0.82
0.07
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
85
0.82
0.07
1.7
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
277
1.05
0.05
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
219
1.05
0.04
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
111
1.08
0.04
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
149
0.94
0.03
2.6
1.8
—
—
—
0
0
(4094501)
13
122
1.07
0.02
1.2
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
94
1.07
0.01
1.4
1.7
pmol/l
171.8
221.9
—
10
87
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
17.7
—
0
9
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
60.3
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.8
—
0
8
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
77
0.91
0.00
1.0
1.2
u/l
16.0
13.6
—
7
64
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
2.9
—
0
8
(3006598) pH of Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
41.7
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
7.6
—
0
8
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_TOXLIV and mortality.

Females

Parameter HR [95% CI] p-value
K11_TOXLIV 2.305 [1.95, 2.72] < 0.001
Birth year 0.995 [0.99, 1.0] 0.287

During the follow-up period (1.1.1998 — 31.12.2019), 482 out of 1710 females with K11_TOXLIV died.

Males

Parameter HR [95% CI] p-value
K11_TOXLIV 3.07 [2.52, 3.74] < 0.001
Birth year 0.99 [0.98, 1.0] 0.036

During the follow-up period (1.1.1998 — 31.12.2019), 519 out of 1402 males with K11_TOXLIV died.

Mortality risk

Mortality risk for people of age

years, who have K11_TOXLIV.

N-year risk Females Males
1 0.296% 0.643%
5 1.451% 3.723%
10 3.399% 8.851%
15 6.4% 17.475%
20 11.149% 28.193%

Relationships between endpoints

↥

Index endpoint: K11_TOXLIV – Toxic liver disease

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data